Aspen Jumps Most in 25 Years on $1.6 Billion Asia Asset Sale

Aspen Pharmacare Holdings Ltd. rallied the most in a quarter-century after Africa’s biggest drugmaker said it will sell its assets in the Asia-Pacific region excluding China to an Australian private equity firm for 26.5 billion rand ($1.6 billion).